The epigenetic state of chromatin, gene activity, and chromosomal positions are interrelated. A research team from the IPK ...

Research in genetics and biotechnology has advanced by leaps and bounds in recent years, offering new hope for the treatment ...

Visualizing cells after editing specific genes can help scientists learn new details about the function of those genes. But ...

It became the first gene-editing treatment that uses the Nobel Prize-winning CRISPR technique, an impressive achievement by CRISPR Therapeutics. Investors scored big wins last year as the S&P 500 ...

Some investors believe you make money when you buy a stock, not when you sell it. The logic behind this idea is that investing in the right stock at the right time -- and holding onto it for a while - ...

Macquarie University researchers have worked with an international team of scientists to achieve a major milestone in ...

Scientists have completed construction of the final chromosome in the worlds' first synthetic yeast genome following more than a decade of work, opening new possibilities for creating resilient, ...

The Alameda, California-based biotech says its gene-editing platform can overcome the limitations of other CRISPR techniques, and also sidesteps the intellectual property infringement issues that ...

CRISPR Therapeutics' stock decline is likely influenced by Editas Medicine's struggles, but CRISPR remains a distinct and stronger company with a promising long-term outlook. CRISPR's strategic ...

The epigenetic state of chromatin, gene activity, and chromosomal positions are interrelated. A research team from the IPK Leibniz Institute (IPK) and the Karlsruhe Institute of Technology (KIT) ...

It became the first gene-editing treatment that uses the Nobel Prize-winning CRISPR technique, an impressive achievement by CRISPR Therapeutics. Investors scored big wins last year as the S&P 500 ...